Werner Mueller

Title: Werner Mueller: Innovator in Pharmaceutical Compositions

Introduction

Werner Mueller is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that incorporate GLP-1 agonists. With a total of six patents to his name, Mueller's work has the potential to impact diabetes treatment and management.

Latest Patents

Among his latest patents is a pharmaceutical composition comprising a GLP-1-agonist and methionine. This liquid composition includes a GLP-1 agonist or a pharmacologically tolerable salt thereof, along with at least one pharmaceutically acceptable excipient. The composition is designed as an add-on therapy with metformin and/or long-acting insulin or insulin derivatives where appropriate. This innovative approach aims to enhance the efficacy of existing diabetes treatments.

Career Highlights

Throughout his career, Werner Mueller has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical therapies.

Collaborations

Mueller has collaborated with several professionals in his field, including Verena Siefke-Henzler and Anette Brunner-Schwarz. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

Werner Mueller's contributions to pharmaceutical innovations, particularly in the area of GLP-1 agonist compositions, demonstrate his commitment to improving diabetes treatment. His patents reflect a deep understanding of the complexities of pharmaceutical formulations and their applications in patient care.